Showing results (191-200 of 201) with videos related to

Sort By:
Pageof 21
Solid-State Electronics|September 28, 2011
Small-Signal Performance and Modeling of sub-50nm nMOSFETs with f above 460-GHzV Dimitrov, J Heng, K Timp, et al.
Nano Letters|December 14, 2011
Tuning ion conducting pathways using holographic polymerizationDerrick M Smith, Bin Dong, Russell W Marron, et al.
Radiation Protection Dosimetry|July 4, 2006
Compact fluorescent lamp phosphors in accidental radiation monitoringK V R Murthy, S P Pallavi, Rahul Ghildiyal, et al.
The Journal of Infectious Diseases|December 7, 2000
Human immunodeficiency virus type 1 quasi species that rebound after discontinuation of highly active antiretroviral therapy are similar to the viral quasi species present before initiation of therapyH Imamichi, K A Crandall, V Natarajan, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|March 16, 2007
Lysophosphatidic acid is detectable in human bronchoalveolar lavage fluids at baseline and increased after segmental allergen challengeS N Georas, E Berdyshev, W Hubbard, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 14, 2009
Synthetic analogs of FTY720 [2-amino-2-(2-[4-octylphenyl]ethyl)-1,3-propanediol] differentially regulate pulmonary vascular permeability in vivo and in vitroS M Camp, R Bittman, E T Chiang, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 30, 2000
Impact of HIV-1 infection and highly active antiretroviral therapy on the kinetics of CD4+ and CD8+ T cell turnover in HIV-infected patientsR A Lempicki, J A Kovacs, M W Baseler, et al.
Nature Medicine|July 14, 1998
Peripheral expansion of pre-existing mature T cells is an important means of CD4+ T-cell regeneration HIV-infected adultsR E Walker, C S Carter, L Muul, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 28, 1999
HIV-1 and T cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppressionR T Davey, N Bhat, C Yoder, et al.
Blood|July 11, 2000
Long-term in vivo survival of receptor-modified syngeneic T cells in patients with human immunodeficiency virus infectionR E Walker, C M Bechtel, V Natarajan, et al.
Pageof 21